FDA Inspection 1309368 — Emergent Biodefense Operations Lansing LLC
The FDA completed an inspection of Emergent Biodefense Operations Lansing LLC on Feb 10, 2026 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 10, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Canton, MA (United States)